Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02852967
What this trial is testing

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Kadmon Corporation, LLC 110
Testing effectiveness (Phase 2)Study completedNCT02762994
What this trial is testing

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 120
Large-scale testing (Phase 3)Study completedNCT00096603
What this trial is testing

Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Who this might be right for
Psoriasis
Genentech, Inc. 450
Early research (Phase 1)UnknownNCT02940561
What this trial is testing

BE Study in Patients - Methotrexate Tablets

Who this might be right for
PsoriasisRheumatoid Arthritis
Amneal Pharmaceuticals, LLC 48
Not applicableStudy completedNCT05863273
What this trial is testing

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

Who this might be right for
Psoriasis
First Hospital of China Medical University 360
Testing effectiveness (Phase 2)Study completedNCT02905006
What this trial is testing

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT06108544
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Who this might be right for
Plaque Psoriasis
Takeda 1,108
Not applicableStudy completedNCT02786186
What this trial is testing

A Registry of Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 2,376
Not applicableStudy completedNCT01084668
What this trial is testing

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

Who this might be right for
Psoriasis Chronic
Abbott 46
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Not applicableStudy completedNCT05155098
What this trial is testing

2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAnkylosing Spondylitis+1 more
Novartis Pharmaceuticals 127
Post-approval studies (Phase 4)Ended earlyNCT02408159
What this trial is testing

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Who this might be right for
Psoriasis
Innovaderm Research Inc. 3
Post-approval studies (Phase 4)UnknownNCT03553433
What this trial is testing

Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis

Who this might be right for
Psoriasis of ScalpPsoriasis Vulgaris
University of Zurich 90
Post-approval studies (Phase 4)Study completedNCT02400749
What this trial is testing

Apremilast in Palmo-Plantar Psoriasis

Who this might be right for
Palmo-plantar Psoriasis
Innovaderm Research Inc. 100
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Early research (Phase 1)Study completedNCT02397382
What this trial is testing

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 16
Testing effectiveness (Phase 2)Study completedNCT02131324
What this trial is testing

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 50
Not applicableEnded earlyNCT00402818
What this trial is testing

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

Who this might be right for
Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 294
Testing effectiveness (Phase 2)Study completedNCT05772520
What this trial is testing

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Hangzhou Highlightll Pharmaceutical Co., Ltd 82
Next Page